The present disclosure provides a composition that may find utility in management of COVID-19. The inventors of the present disclosure surprisingly observed that ingredients of the composition of the present disclosure exhibit functional synergy therebetween, wherein the composition prevents virus replication and/or Virus entry into human cells, either wholly or in part, while modulating immune response of the patient. Hence, the composition of the present disclosure holds potential for wide spread usage in management of COVID-19, either alone or in combination with other preventive or palliative/symptomatic or therapeutic strategies.

The present disclosure provides a composition that may find utility in management of COVID-19. The inventors of the present disclosure surprisingly observed that ingredients of the composition of the present disclosure exhibit functional synergy therebetween, wherein the composition prevents virus replication and/or Virus entry into human cells, either wholly or in part, while modulating immune response of the patient. Hence, the composition of the present disclosure holds potential for wide spread usage in management of COVID-19, either alone or in combination with other preventive or palliative/symptomatic or therapeutic strategies.

The present disclosure provides a composition that may find utility in management of COVID-19. The inventors of the present disclosure surprisingly observed that ingredients of the composition of the present disclosure exhibit functional synergy therebetween, wherein the composition prevents virus replication and/or Virus entry into human cells, either wholly or in part, while modulating immune response of the patient. Hence, the composition of the present disclosure holds potential for wide spread usage in management of COVID-19, either alone or in combination with other preventive or palliative/symptomatic or therapeutic strategies.

The present invention includes a novel means for destroying aggressive mold in a system. A foreign target antagonist both draws and depletes defense mechanisms for the mold at which point the mold may be attacked with conventional anti-fungal preparations. A more preferred means for destroying the mold includes the post-depletion application of a mold indirect antagonist adapted to ameliorate cellular organelle deformation in the organism. In this preferred means, the organism overcomes the mold with its inherent biodefense mechanisms.

The present invention includes a novel means for destroying aggressive mold in a system. A foreign target antagonist both draws and depletes defense mechanisms for the mold at which point the mold may be attacked with conventional anti-fungal preparations. A more preferred means for destroying the mold includes the post-depletion application of a mold indirect antagonist adapted to ameliorate cellular organelle deformation in the organism. In this preferred means, the organism overcomes the mold with its inherent biodefense mechanisms.

A nasal balm including, by weight, 10-50% of shea butter; 10-50% of coconut oil; 10-50% of Cera alba; 1-5% of grapefruit peel oil; 1-10% of Sclerocarya birrea seed oil; 1-10% of Moringa pterygosperma seed oil; and 1-10% of Simmondsia chinensis seed oil.

A nasal balm including, by weight, 10-50% of shea butter; 10-50% of coconut oil; 10-50% of Cera alba; 1-5% of grapefruit peel oil; 1-10% of Sclerocarya birrea seed oil; 1-10% of Moringa pterygosperma seed oil; and 1-10% of Simmondsia chinensis seed oil.

A nasal balm including, by weight, 10-50% of shea butter; 10-50% of coconut oil; 10-50% of Cera alba; 1-5% of grapefruit peel oil; 1-10% of Sclerocarya birrea seed oil; 1-10% of Moringa pterygosperma seed oil; and 1-10% of Simmondsia chinensis seed oil.

A composition for strengthening skin barrier or improving skin barrier function is able to improve objective indicators related to the protection of skin barrier, the strengthening of skin barrier, and/or the improvement of skin barrier function. The composition exhibits the effects of increasing the amount of ceramides, dihydroceramides and sphingoid bases, increasing the activities of enzymes that are involved in the synthesis thereof, and decreasing the activities of enzymes that are involved in the degradation thereof. In addition, the composition is able to restore skin barrier function by reducing TSLP, IL-4, and IL-13 which are closely associated with skin barrier damage, and thus interrupting a vicious circle in which the lipids and proteins contributing to skin barrier decrease.

A composition for strengthening skin barrier or improving skin barrier function is able to improve objective indicators related to the protection of skin barrier, the strengthening of skin barrier, and/or the improvement of skin barrier function. The composition exhibits the effects of increasing the amount of ceramides, dihydroceramides and sphingoid bases, increasing the activities of enzymes that are involved in the synthesis thereof, and decreasing the activities of enzymes that are involved in the degradation thereof. In addition, the composition is able to restore skin barrier function by reducing TSLP, IL-4, and IL-13 which are closely associated with skin barrier damage, and thus interrupting a vicious circle in which the lipids and proteins contributing to skin barrier decrease.